5 Things to Know Before the Opening Bell 10/1/2025
Friday’s employment report is unlikely to be released due to the government shutdown, the White House is pulling the nomination of economist E.J. Antoni to lead the Bureau of Labor Statistics, Tesla i...
1 Loka 20253min
The Shutdown Episode: Speaker Johnson & Minority Leader Jeffries 9/30/25
As a government shutdown looms in Washington, House Speaker Mike Johnson (R-Louisiana) discusses friction between the Republicans and Democrats that’s delaying progress on the Hill. House Minority Lea...
30 Syys 202548min
Jim Cramer, “How to Make Money in Any Market,” & NYC Politics 9/29/25
CNBC’s Jim Cramer is out with a new book this week, “How to Make Money in Any Market.” He joins Becky Quick and Andrew Ross Sorkin on the Squawk Box set to discuss his perspective on the markets, the ...
29 Syys 202541min
5 Things to Know Before the Opening Bell 9/29/2025
The 5 things you need to know before the stock market opens today: Jeep-maker Stellantis has a new CFO, the CEO of British drugmaker GSK is stepping down, SEC Chair Paul Atkins is moving to fast track...
29 Syys 20251min
Global Takes on a TikTok Deal & “The Creative Shift” 9/26/25
President Trump has approved a TikTok deal; CNBC’s Eamon Javers, in Washington, and Eunice Yoon, in Beijing, discuss the geopolitics playing out through the social media platform’s business. A governm...
26 Syys 202545min
5 Things to Know Before the Opening Bell 9/26/2025
The 5 things you need to know before the stock market opens today: President Trump has announced new tariffs on pharmaceuticals and trucks, and he’s suggested sharing that revenue with American farmer...
26 Syys 20252min
Shutdown, What Shutdown? & Kodiak’s Nasdaq Launch
The White House warned federal agencies to prepare for mass firings if Congress does not reach a deal to fund the government by midnight on October 1st. CNBC’s Emily Wilkins describes the warning, and...
25 Syys 202535min
Merck CEO & Kimmel’s Return 9/24/25
The FDA has approved the injectable version of Merck’s cancer therapy Keytruda. Merck CEO Robert Davis discusses the pricing of this drug and others with CNBC’s Angelica Peebles, Joe Kernen, Becky Qui...
24 Syys 202540min
